Responding to widespread outrage over high-profile price hikes for prescription drugs, a Senate committee is holding a meeting on Wednesday to grill pharmaceutical executives on their business practices.
While House Democrats have already set up a task force to scrutinize price hikes, the hearing scheduled by the Special Senate Committee on Aging over the matter means that the majority party is taking an interest in the issue as well.
In particular, reports the Wall Street Journal, the committee is investigating the implications of companies that are buying the rights to medical patents and then dramatically raising the price.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
